NR566 / NR 566 Final Exam () –
Advanced Pharmacology for Care of the
Family | Chamberlain University | Verified
Questions & Answers | A+ Graded
ADVANCED PHARMACOLOGY FOR CARE OF THE FAMILY – CHAMBERLAIN
100 VERIFIED QUESTIONS & ANSWERS WITH DETAILED RATIONALES LATEST
CURRICULUM | A+ GRADED | 100% PASS GUARANTEED
Q1. First-line treatment for uncomplicated UTI in non-pregnant women? Nitrofurantoin 100
mg BID × 5 days. Rationale: IDSA 2024: avoids collateral damage; excellent urinary
concentration.
Q2. Patient on warfarin starts amiodarone. What adjustment is needed? Decrease warfarin dose
by 25–50%. Rationale: Amiodarone inhibits CYP2C9 → ↑ INR dramatically.
Q3. Black box warning for fluoroquinolones? Tendonitis/tendon rupture, peripheral
neuropathy, CNS effects. Rationale: Reserve for no alternative treatment options.
Q4. Which antibiotic requires serum level monitoring? Vancomycin (trough 10–20 mcg/mL
for serious infections). Rationale: Narrow therapeutic index; nephrotoxicity/ototoxicity risk.
Q5. Patient with penicillin allergy (anaphylaxis) needs treatment for syphilis. Best option?
Doxycycline 100 mg BID × 14 days (early); or desensitize to penicillin. Rationale: CDC
2024: penicillin is drug of choice; doxycycline alternative.
Q6. Maximum daily dose of acetaminophen in adults? 3,000–4,000 mg (3,000 mg in liver
disease/alcohol use). Rationale: FDA 2024: hepatotoxicity risk.
, Q7. First-line treatment for acute gout flare? Colchicine 1.2 mg ×1, then 0.6 mg 1 hr later
(max 1.8 mg). Rationale: ACR 2024: lower dose safer in renal impairment.
Q8. Patient on atorvastatin 80 mg reports muscle pain. Next step? Check CK; hold statin;
consider rhabdomyolysis. Rationale: Statin-induced myopathy; rosuvastatin or pravastatin
alternatives.
Q9. Which statin does NOT interact with grapefruit juice? Pravastatin. Rationale: Not
metabolized by CYP3A4.
Q10. Treatment of choice for opioid overdose? Naloxone (Narcan) 0.4–2 mg IV/IM/IN.
Rationale: Mu-opioid receptor antagonist; repeat q2–3 min.
Q11. Patient on levothyroxine has TSH 8.2 (high). Next action? Increase levothyroxine dose by
25–50 mcg/day. Rationale: Goal TSH 0.4–4.0 mU/L; adjust every 6 weeks.
Q12. Contraindication to metformin? eGFR <30 mL/min; acute heart failure; alcohol abuse.
Rationale: Lactic acidosis risk.
Q13. First-line treatment for type 2 diabetes (ADA 2024)? Metformin + lifestyle + GLP-1 RA
or SGLT2i if ASCVD/HF/CKD. Rationale: Cardiorenal protection.
Q14. Which insulin has peakless action? Glargine (Lantus), degludec (Tresiba), detemir.
Rationale: Long-acting basal insulins.
Q15. Patient on spironolactone develops gynecomastia. Next step? Switch to eplerenone.
Rationale: Eplerenone has less anti-androgenic effect.
Advanced Pharmacology for Care of the
Family | Chamberlain University | Verified
Questions & Answers | A+ Graded
ADVANCED PHARMACOLOGY FOR CARE OF THE FAMILY – CHAMBERLAIN
100 VERIFIED QUESTIONS & ANSWERS WITH DETAILED RATIONALES LATEST
CURRICULUM | A+ GRADED | 100% PASS GUARANTEED
Q1. First-line treatment for uncomplicated UTI in non-pregnant women? Nitrofurantoin 100
mg BID × 5 days. Rationale: IDSA 2024: avoids collateral damage; excellent urinary
concentration.
Q2. Patient on warfarin starts amiodarone. What adjustment is needed? Decrease warfarin dose
by 25–50%. Rationale: Amiodarone inhibits CYP2C9 → ↑ INR dramatically.
Q3. Black box warning for fluoroquinolones? Tendonitis/tendon rupture, peripheral
neuropathy, CNS effects. Rationale: Reserve for no alternative treatment options.
Q4. Which antibiotic requires serum level monitoring? Vancomycin (trough 10–20 mcg/mL
for serious infections). Rationale: Narrow therapeutic index; nephrotoxicity/ototoxicity risk.
Q5. Patient with penicillin allergy (anaphylaxis) needs treatment for syphilis. Best option?
Doxycycline 100 mg BID × 14 days (early); or desensitize to penicillin. Rationale: CDC
2024: penicillin is drug of choice; doxycycline alternative.
Q6. Maximum daily dose of acetaminophen in adults? 3,000–4,000 mg (3,000 mg in liver
disease/alcohol use). Rationale: FDA 2024: hepatotoxicity risk.
, Q7. First-line treatment for acute gout flare? Colchicine 1.2 mg ×1, then 0.6 mg 1 hr later
(max 1.8 mg). Rationale: ACR 2024: lower dose safer in renal impairment.
Q8. Patient on atorvastatin 80 mg reports muscle pain. Next step? Check CK; hold statin;
consider rhabdomyolysis. Rationale: Statin-induced myopathy; rosuvastatin or pravastatin
alternatives.
Q9. Which statin does NOT interact with grapefruit juice? Pravastatin. Rationale: Not
metabolized by CYP3A4.
Q10. Treatment of choice for opioid overdose? Naloxone (Narcan) 0.4–2 mg IV/IM/IN.
Rationale: Mu-opioid receptor antagonist; repeat q2–3 min.
Q11. Patient on levothyroxine has TSH 8.2 (high). Next action? Increase levothyroxine dose by
25–50 mcg/day. Rationale: Goal TSH 0.4–4.0 mU/L; adjust every 6 weeks.
Q12. Contraindication to metformin? eGFR <30 mL/min; acute heart failure; alcohol abuse.
Rationale: Lactic acidosis risk.
Q13. First-line treatment for type 2 diabetes (ADA 2024)? Metformin + lifestyle + GLP-1 RA
or SGLT2i if ASCVD/HF/CKD. Rationale: Cardiorenal protection.
Q14. Which insulin has peakless action? Glargine (Lantus), degludec (Tresiba), detemir.
Rationale: Long-acting basal insulins.
Q15. Patient on spironolactone develops gynecomastia. Next step? Switch to eplerenone.
Rationale: Eplerenone has less anti-androgenic effect.
